13F Portfolios

EcoR1 Capital, LLC: ETON PHARMACEUTICALS INC (ETON): Quarterly 13F Position History

As of Q1 2026, EcoR1 Capital, LLC reported 2,171,938 shares of ETON PHARMACEUTICALS INC (ETON), worth $53.6M and representing 2.3% of its 13F equity book. Quarter-over-quarter share count change: + 141,394 (+7.0%) . The position first appeared in Q3 2024 and has been disclosed across 7 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 2,171,938 +141,394 +7.0% $53.6M 2.3% $24.7
Q4 2025 2,030,544 0 $34.3M 1.6% $16.9
Q3 2025 2,030,544 0 $44.1M 2.1% $21.7
Q2 2025 2,030,544 +91,256 +4.7% $28.9M 1.7% $14.3
Q1 2025 1,939,288 +109,685 +6.0% $25.2M 1.5% $13.0
Q4 2024 1,829,603 +1,263,528 +223.2% $24.4M 1.0% $13.3
Q3 2024 566,075 $3.4M 0.1% $6.0

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did EcoR1 Capital, LLC first disclose a ETON position in 13F-HR filings?

EcoR1 Capital, LLC first reported ETON PHARMACEUTICALS INC (ETON) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.

What was EcoR1 Capital, LLC's most recent quarter-over-quarter share-count change in ETON?

Between Q4 2025 and Q1 2026, EcoR1 Capital, LLC added 141,394 shares of ETON (+7.0%), bringing the total reported position to 2,171,938 shares at a market value of $53.6M.

Does the implied price-per-share represent EcoR1 Capital, LLC's cost basis in ETON?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.